Collectively, these data illustrate that hepcidin is significantly increased in active IBD patients in comparation with that in remitted IBD patients and healthy controls and that hepcidin in IBD patients is relevant to disease activity, CRP, and ESR, respectively. Here, CRP is linked to inflammatory bowel disease.